Renal day 2 Flashcards

1
Q

Urine Output

A

Standards
Daily output averages 1000 – 2400 ml / day
Normal adult approximately 1500 mL/day
Acute Care Setting: 30 ml / hour (720 ml / day)

Oliguria: 100 – 400 ml / day
Aging kidney’s lose ability to concentrate
Older adults may be oliguric with volumes of 600 – 700 / day

Anuria: < 100 ml / day

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Acute Renal Failure: Causes

A

Primary causes in Acute Care:
Hypotension
Hypovolemia

Pre-Renal
Intra-Renal
Post-Renal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Pre-Renal Causes

A

Issues that interfere with renal perfusion
Circulatory volume depletion
Volume shifts
“3rd Spacing”
Decreased cardiac output
Decreased PVR
Vascular Obstruction

General Symptoms
High specific gravity & osmolarity
Normal sediment
May have Hyaline/Granular casts
BUN / Cr significantly elevated (10:1 – 40:1)
Proteinuria & sodium excretion not significant

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Intra-Renal Causes

A

Parenchymal changes caused by disease or nephrotoxins
Acute tubular necrosis (75%)
Muddy brown granular casts
Glomerulonephritis
Hematuria
RBC & Hemoglobin casts
Vascular lesions
Cortical necrosis (Prolonged vasospasm)
Tissue damage - Elevated
Serum creatinine
Phosphokinase
K+

General Symptoms:
Fixed specific gravity
Edema
Weight gain
Hemoptysis
Elevated LV EDP
Weakness (Anemia)
Hypertension
High urine sodium
Proteinuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Post-Renal Causes

A

Issues that cause obstruction of urinary tract
BPH
Calculi
Tumor
Surgical accident

Spinal cord injury
Neurogenic bladder with retention (decreased bladder emptying)
“Functional” obstruction

General Symptoms
Fixed specific gravity
Elevated urine sodium
Little or no proteinuria
Sediment normal
Indications of obstruction
Anuria / Polyuria: Intermittent?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Acute Kidney Injury: Elderly Considerations

A

Decreased GFR with aging

More susceptible to AKI & decreased ability to recover
Dehydration
Polypharmacy (Diuretics, laxatives)
Illness
Immobility
Hypotension, diuretic therapy, aminoglycoside therapy, obstructive disorders, surgery, infection, & contrast medium

Renal Replacement Therapies (RRT) still an option

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Acute Kidney Injury: Oliguric Phase

A

U.O. < 400 ml / day
Occurs: 1 – 7 days of injury (24 - hours ischemia)
Duration: 10 – 14 days to months
Longer phase = poorer prognosis
50% patients non-oliguric; > 400 mL urine/day

Urinalysis; Casts, RBCs, WBCs, Protein

Specific gravity 1.010 (Fixed)

Osmolality 300 mOsm/kg

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Acute Kidney Injury: Oliguric Phase cont

A

Hypovolemia may exacerbate AKI

Decreased urine output leads to fluid retention
Neck veins distended
Bounding pulse
Edema
Hypertension
Fluid overload can lead to:
CHF
Pulmonary edema
Pericardial or pleural effusions

Leukocytosis: Infection may be fatal
Urinary & respiratory
Waste product accumulation; Increased BUN & Cr

Neurologic disorders
Fatigue
Difficulty concentrating
Seizures, stupor, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Metabolic acidosis

A

Kidneys cannot excrete Hydrogen or acid products of metabolism
Serum bicarbonate production decreased; Reabsorption & regeneration defective
Severe acidosis develops; Kussmaul respirations (increase exhaled CO2)

Results from
Impaired ability of kidneys to excrete excess acid
Defective reabsorption & regeneration of bicarbonate
Plasma bicarbonate level usually falls to approximately 16 to 20 mEq/L (16 to 20 mmol/L)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Hyponatremia

A

Increased excretion of Na+ d/t damaged tubules
Can lead to cerebral edema

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Hyperkalemia

A

Impaired ability to excrete K+
Usually asymptomatic; Peaked T waves, Wide QRS, ST depression
Increased risk with massive tissue trauma

Weakness, cardiac arrhythmias
EKG Monitoring / Remote Telemetry

Treatment:
K+ restriction
Potassium removal
Dialysis
Kayexalate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Acute Kidney Injury: Diuretic Phase

A

Lasts 1 – 3 weeks
Daily U.O. 1 - 3 Liters (up to 5 Liters)
Osmotic diuresis from high urea
Low specific gravity; Nearly iso-osmolar
Kidneys able to excrete waste, but not concentrate urine

Patients who develope oliguria will have greater diuresis than those who do not
Monitor for:
Hypovolemia,
Hypotension
Hyponatremia
Hypokalemia
Dehydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Acute Kidney Injury: Recovery Phase

A

Begins when GFR increases
Allows BUN & Cr to plateau & then decrease

Major improvements occur in first 1 – 2 weeks

May take up to 12-months to stabilize

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

AKI: Diagnostics

A

Thorough history
Serum BUN / Cr
Serum electrolytes
Urinalysis
Renal ultrasound
Renal CT scan
Renal biopsy

Contraindications: Contrast
MRI or MRA with Gadolinium (May be fatal)
Contrast-induced nephropathy
Metformin: Hold 48-hours before & after use of contrast; Risk for lactic acidosis
If contrast needed for high-risk patients - Use low-dose & ensure optimal hydration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

AKI: Interprofessional Care

A

Goals of Care:
Eliminate cause
Manage signs/symptoms
Prevent complications
Ensure adequate intravascular volume & cardiac output
Loop diuretics: Furosemide (Lasix)
Osmotic diuretics: Mannitol

Closely monitor fluid intake during Oliguric phase
Fluid restriction: All fluid losses for previous 24 hours + 600 mL
Expected outcomes:
Regain & maintain normal fluid & electrolyte balance
Adhere to treatment regimen
No complications
Complete recovery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Electrolytes

A

K+ (3.5 – 5.0 mEq/L)
Na+ (136 – 145 mEq/L)
Mg+ (1.3 – 2.1 mEq/L)
Phosphorous (3.0 – 4.5 mg/dL)
Ca+ (Parathyroid function)
Total 9.0 – 10.5 mg/dL
Ionized 4.5 – 5.6 mg/dL

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Exchange Resins

A

Kayexalate & Sorbitol
Questions re: efficacy versus risks
Contra-indicated with ileus (Intestinal necrosis)

Patiromer (Veltassa)
Powder for oral suspension in water
Taken daily; Delayed action - Not for emergency use

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Indications for Renal Replacement Therapy (RRT)

A

Volume overload
Hyperkalemia
Metabolic acidosis
BUN > 120 mg/dL
Significant change in mental status
Pericarditis, pericardial effusion, or cardiac tamponade
Clinical status of patient

Hemodialysis (HD): Emergent therapy
Peritoneal dialysis (PD)

ICU Setting Only:
Continuous Renal Replacement Therapy (CRRT)
Continuous cannulation (24-hours) of artery & vein

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

AKI: Nutritional Therapy

A

Maintain adequate caloric intake
Primarily carbohydrates, increased fats, adequate protein to prevent breakdown
Restrict Na+, K+, Phosphate
Calcium supplements or phosphate-binding agents
Enteral / parenteral nutrition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Acute Care

A

Accurate I & O
Daily weights
Assess for hypervolemia or hypovolemia
Assess for K+ & Na+ disturbances
Meticulous aseptic technique
Careful use of nephrotoxic drugs
Skin care measures
Oral care

Patient Teaching for Post-Acute Ambulatory Care
Monitor kidney function
Regulate protein & potassium intake
Follow-up care
Teaching
Appropriate referrals

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Chronic Kidney Disease (CKD)

A

Progressive, irreversible loss of kidney function
Low glomerular filtration rate (GFR); <60 mL/min/1.73m2 for longer than 3 months

More than 26 million American adults have CKD
Increased prevalence: Aging population, increased obesity, increased diabetes & HTN
Increased incidence: Blacks, Native Americans, & Latinos

Underdiagnoses & untreated; Many with CKD are asymptomatic; Approximately 70% aware

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Uremia

A

Syndrome; Kidney function declines to point that symptoms occur in multiple body systems

Often occurs when GFR is less than or equal to 15mL/min

Manifestations vary depending on cause, co-morbidities, age, & adherence to medical regimen

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Diagnostic Studies

A

H & P
Dipstick evaluation of protein; Albuminuria
Urinalysis
Renal ultrasound, scan, CT scan, biopsy
Albumin-to-creatinine ratio (1st AM void)
Serum BUN, creatinine, creatinine clearance, electrolytes, lipids, hemoglobin, hematocrit
GFR

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Stages of Chronic Kidney Disease

A

1
≥ 90
Diagnosis and treatment; CVD risk reduction; slow progression

2
60–89
Estimation of progression

3a
45–59
Evaluation and treatment of complications

3b
30–44
More aggressive treatment of complications

4
15–29
Preparation for RRT (dialysis or transplant)

5
Less than 15 or dialysis
RRT if uremia present and patient desires treatment; necessary to maintain life

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
CKD: Sodium / Magnesium
HYPOnatremia (Dilutional) Confusion, seizures, coma Fluid restriction for self-correction HYPERmagnesemia Decreased reflexes, mental status, B/P, respiratory failure Avoid: Dark green veggies Grains, seeds, nuts Legumes Antacids with Mg+ Osmotic laxatives (Milk of Magnesia, Magnesium Citrate)
26
CKD: Calcium / Phosphorous
HYPOcalcemia Decreased intestinal Ca+ absorption Synthesis of 1,25 dihydroxyycholecalciferol HYPERphosphatemia furthers low Ca+ Increased parathyroid hormone excretion leads to bone resorption Osteomalacia Osteitis fibrosa Osteosclerosis HYPERphosphatemia Hypocalcemia Increased risk for fractures, CKD-MBD Avoid: Dairy products & foods containing dairy products Milk Ice cream Cheese Yogurt Pudding Protein sources contain Phosphate Phosphate binders
27
As Glomerular Filtration Rate (GFR) Falls
Parathyroid hormone levels increase Activated form of Vitamin D falls Old thinking: This was just decreased production of 1,25(OH)2D New understanding: Degradative pathways are up-regulated (some induced by FGF-23) Fall in 1,25(OH)2D is physiological with CKD Makes sense because you do not want a lot of 1,25(OH)2D around to cause more calcium & phosphorus absorption when you cannot excrete these ions
28
Mechanisms of CKD-MBD
Systemic disorder of mineral & bone metabolism results in: Skeletal complications (Osteomalacia, osteitis fibrosa) Soft tissue complications (Vascular calcifications) Phosphate not restricted until patient requires RRT Then Phosphate restricted to < 1 g/day
29
Hypertension & Elevated Triglycerides
HTN; Cause & consequence of CKD Aggravated by Na+ & H20 retention Increased renin production may contribute HTN, ECF volume overload, & anemia may develop into LV hypertrophy, which may lead to cardiomyopathy & HF HTN can cause retinopathy, encephalopathy, nephropathy B/P control; One of most important goals Dysrhythmias; Hyperkalemia & Decreased coronary artery perfusion Hyperinsulinemia stimulates hepatic production of triglycerides Altered lipid metabolism Decreased levels of enzyme lipase (Important in breakdown of lipoproteins) Increased VLDLs & LDLs Decreased HDLs
30
CKD & CV Disease Are Closely Linked
Death often r/t MI, ischemic heart disease, PAD, HF, cardiomyopathy, and/or stroke Traditional CV risk factors; HTN & Elevated lipids Nontraditional CV risk factors; Vascular calcification & arterial stiffness Calcium deposits associated with stiff blood vessels Vascular smooth muscle cells change High Ca+ & phosphate Impaired renal excretion Drug therapies to treat bone disease
31
Altered Carbohydrate Metabolism
Caused by impaired glucose metabolism (Cellular insensitivity to normal action of insulin) Mild-moderate hyperglycemia Hyperinsulinemia Uremic patients with DM may require less insulin than before onset of CKD Excretion of insulin dependent on kidneys Insulin dosing must be individualized May improve after starting dialysis
32
CKD: Hematologic Changes
Decreased production of erythropoietin Other factors: Nutritional deficiencies Decreased RBC life span, HD & Increased hemolysis Blood sampling GI bleeding Increased Parathyroid hormone Decreased iron stores Folic acid lost in dialysis Bleeding tendencies Defect in platelet function Infection Change in WBC function Altered immune response & function Hyperglycemia External trauma
33
CKD: Every Part of GI System Affected
Cause: Excessive Urea Stomatitis with exudates & ulcerations Uremic fetor (Urine odor to breath) Anorexia, nausea, vomiting Diabetic gastroparesis GI bleeding Constipation significant problem Phosphate-binding medications are constipating Cannot be managed by increasing PO fluids, or taking Magnesium or fiber / bulk forming laxatives Probiotics, stool softeners, use of footstool when defecating
34
CKD: CNS Manifestations
CNS depression Lethargy, apathy Decreased ability to concentrate Fatigue, irritability Altered mental ability (late sign) Seizures Coma Hypertensive encephalopathy Peripheral neuropathy Restless legs syndrome Paresthesias Motor involvement Foot drop Muscle weakness & atrophy Loss of deep tendon reflexes Muscle twitching, jerking, asterixis, & nocturnal leg cramps
35
CKD: Metabolic Changes
Carbohydrate intolerance Peripheral insulin antagonism Impaired insulin secretion Prolonged insulin half-life Abnormal circulating insulin ** Short acting insulin functions as longer acting ** Patients on dialysis may need less insulin for glucose control Elevated triglycerides Metabolic acidosis Pericarditis
36
Acid-Base Balance
Normal pH: 7.35 – 7.45 Normal Base Excess: 0 +/- 3 mEq / L Calculated with ABG results using pH, PC02 & HCT Represents amount of buffering ions in blood Largest = HCo3- Hemoglobin, Proteins, Phosphates, Etc… Negative (-) BE indicates metabolic (lactic) acidosis Positive (+) BE indicates metabolic alkalosis or compensation to respiratory acidosis
37
CKD: Reproductive & Other Manifestations
Infertility & decreased libido Experienced by both sexes: Low sperm counts, amenorrhea Sexual dysfunction; Physical, psychological, & medication side effects Pregnancy during dialysis poses significant risk to mother & fetus Pruritus Calcium-phosphate deposits Sensory neuropathy May be intense Leads to bleeding or infection Uremic frost Urea crystalizes on skin BUN > 200 mg/dL
38
CKD: Renal Diet
Adequate calories 30 – 35 kcal / Kg Primarily from Carbs & Fat (30 – 40% to prevent / reduce catabolism) Protein 0.8 – 1.0 Gm / Kg / day Avoid high-protein, fad diets Greater needs in end-stage K+ / Na+ regulated to plasma levels Restrict Na+ to prevent edema Phosphate restriction 1 gram per day Avoid foods high in phosphate (Meat & dairy) Most foods high in phosphate are high in protein Phosphate binders essential with dialysis
39
CKD: Interprofessional Care
Overall goals Preserve existing kidney function Reduce risks of CV disease Prevent complications Provide for comfort Early recognition and treatment important Nephrology referral Identify & treat reversible causes Management Stage 1 to 4: Control: HTN Hyperparathyroidism CKD-MBD Anemia Dyslipidemia Correct ECF overload or deficit RRT Treat CV disease Nutritional therapy Drug therapy
40
Medications for CRF
Antihypertensives Diuretics Calcium Prophylactic antibiotics Vitamins, Minerals & Phosphate binders
41
Antihypertensives: Angiotension-Converting Enzyme (ACE) Inhibitors
Slow progression or delay onset of Diabetic nephropathy (Example: Captopril) Dilate arterioles & veins Reduce blood volume (effect on kidneys) Reduce glomerular filtration pressure Suppress formation of Angiotension II 1st dose hypotension Hyperkalemia Vasodilation Increase bradykinin (Inhibit Kinase II) Cough & angioedema
42
Angiotension II Receptor Blockers (ARB’s)
Prevent Angiotension II mediated vasoconstriction & release of Aldosterone Produce effects similar to ACE inhibitors No cough No angio-edema Diabetic nephropathy Irbesartan (Avapro) Losartan (Cozaar)
43
Diuretics
Furosemide (Lasix) Blocks re-absorption of Na+ & Cl- at ascending LOH Diuresis despite low renal blood flow & GFR Onset: 5-minutes Duration: 2-hours Hypotension Hypokalemia Ototoxicity (IVP: 20 - 40 mg over 1 - 2 minutes) Mannitol (5% - 25%) Creates osmotic force within nephron Diuresis of fluid only Onset: 30 – 60 minutes Duration: 6 – 8 hours Edema May precipitate CHF / Pulmonary edema Observe for crystals Filter needle
44
Medications for Dyslipidemia
Statins (HMG-CoA reductase inhibitors) Most effective for lowering LDL Atorvastatin (Lipitor) Fibrates (Fibric acid derivatives) Used to lower triglyceride levels & increase HDL Gemfibrozil (Lopid)
45
Vitamins, Minerals & Binders
Calcium Cinacalcet (Sensipar) Increases sensitivity of Ca+ receptors in parathyroid glands Subtotal or total parathyroidectomy Vitamin D: Calcitriol (Rocaltrol) 0.5 – 1.0 mcg / daily Treats hypoparathyroidism & hypocalcemia Serum phosphate must be lowered before Calcium or Vitamin D is administered Avoid aluminum & magnesium preparations Folic Acid Phosphate binders (Reduce intestinal absorption) Bind phosphate in bowel & then excrete Ca+ based Calcium carbonate (Caltrate) Calcium acetate (PhosLo) Ca+ free Sevelamer (Renagel) – Lowers cholesterol & LDL
46
Treatments for Anemia
Iron supplements If plasma ferritin <100 ng/mL Side effects: GI irritation, constipation May make stool dark in color Folic acid supplements Needed for RBC formation Removed by dialysis Avoid blood transfusions Increase development of antibodies May lead to iron overload Epoetin alfa (Epogen, Procrit) Darbepoeitin alfa (Aranesp) Given IV or SQ Expect increased H & H in 2 - 3 weeks Side effects: Thromboembolism, HTN
47
Inter-dialetic Weight Gain
Weight gain between dialysis treatments Rationale for fluid restriction Measure of adherence 1 – 3 Kg advised (2.2 to 6.6 pounds)
48
Fluid & Electrolyte Balance
Careful fluid replacement Calculated fluid restriction = 24-hour loss + 600 ml insensible Daily weights Fluid restriction (1000 – 1500 mL / Day) Diuretics Furosemide (Lasix) Bumetanide (Bumex) Mannitol
49
Managing Fluid Restriction in Acute Care
1000 – 1500 mL/day (Average fluid restriction for CKD) Acute Care RN responsible to supervise & maintain ordered fluid restriction from all sources: PO Enteral nutrition, & free water flushes Parenteral nutrition Maintenance IV Continuous IV medications (Ex: Heparin, Nexium) Intermittent IV medications (Ex: Antibiotics, others)
50
Dialysis Access: A Dialysis Patient’s Life Line
Temporary Dialysis Catheter Double-lumen, non-tunneled CVAD 13 – 20 cm long, 13G or less, No cuff, Rigid Permanent Dialysis Catheter (“PermCath”) Tunneled, cuffed at skin/exit site Arterio-venous Fistula (AVF) Arterio-venous Graft (AVG) HeRO Graft Used when other options have failed Bypasses venous system; blood flow directly from target artery from the heart More difficult to assess Thrill / Bruit d/t no venous anastomosis Peritoneal Dialysis Catheter
51
Temporary Vascular Access
Insertion at internal jugular or femoral vein when immediate access needed Double lumen Blood removal Blood return Risks: Infection Dislodgment Malfunction
52
Assessment of Dialysis Access
A-V Fistula A-V Graft Assess for bleeding / bruising (after Hemodialysis) Assess for patency Auscultate for “Bruit” Palpate for “Thrill”
53
Dry Weight
Usually reflects lowest weight a patient can tolerate without intra-dialytic symptoms or hypotension Imprecise trial-and-error method Does not account for changes in nutritional status & lean body mass Difficult to determine over- or under-hydration Used to calculate ultra-filtration (UF) volume & rates for dialysis treatment
54
Physiologic Dry Weight
Weight resulting from Normal renal function Vascular permeability Serum protein concentration Body volume regulation Patients theoretically should be lower than physiologic to be prophylactic for inter-dialytic weight gain
55
Renal Replacement Therapies (RRT)
Intermittent (Hemodialysis, Peritoneal dialysis) Continuous (CRRT) in Critical Care Toxins/fluids removed Acid-Base balance & electrolytes adjusted slowly in hemodynamically UNSTABLE patients Access: Double-lumen catheter in Jugular or Femoral veins Blood pump & anti-coagulation required Renal Transplantation
56
Funding for Chronic Diseases
1972 Social Security Amendment - Medicare Coverage for all those: 65 or older Under 65 with certain disabilities (DM, HTN) & those who have received Social Security Disability (SSDI) for 2-years Any age with ESRD 1978: Congress established ESRD Network Organizations Program 1986: Program re-codified to 18 ESRD Network Organization areas, Funding for Renal Transplantation
57
Dialysis
Movement of fluid/molecules across semipermeable membrane from one compartment to another Used to correct fluid & electrolyte imbalances, & remove waste products in kidney failure Can be used to treat drug overdoses Two methods available Peritoneal dialysis (PD) Hemodialysis (HD) Nephrologist determines when to start; Usually uremia can no longer be adequately treated conservatively; GFR < 15 mL/min/1.73 m2 Uremic complications require dialysis ESRD treated with dialysis because Lack of donated organs Some patients are physically or mentally unsuitable for transplantation Some patients do not want transplantation
58
General Principles of Dialysis
Diffusion; Movement of solutes from an area of greater concentration to an area of lesser concentration Osmosis; Movement of fluid from an area of lesser concentration of solutes to area of greater concentration Glucose in dialysate creates osmotic gradient to pull fluid from the blood Ultrafiltration; Water & fluid removal results when there is an osmotic gradient or pressure gradient across membrane, excess fluid moves into dialysate PD: Glucose in dialysate HD: Pressure gradient
59
Peritoneal Dialysis
Access obtained by inserting catheter through anterior abdominal wall Technique for placement varies; usually done via surgery PD may start right away or be delayed until site healed Aseptic technique important to avoid peritonitis
60
Peritoneal Dialysis: Dialysis Solutions & Cycles
Dextrose in dialysis solution; Osmotic agent Manual PD: 3-Phase Cycle (Called an “Exchange”) Volume depends on size of peritoneal cavity Inflow (fill); 2 to 3 Liters over 10-minutes Dwell (equilibration); 20 - 30 minutes to 8-hours (Individualized) Drain; 15 - 30 minutes Continuous Ambulatory Peritoneal Dialysis (CAPD) Manual exchange 4 x / Day Automated Peritoneal Dialysis (APD) Cycler delivers dialysate during sleep Times & controls fill, dwell, & drain phases Alarms & monitors for safety
61
Peritoneal Dialysis Complications
Exit site infection Redness, tenderness, drainage Treated with antibiotics Peritonitis: Exit site or tunnel infection Abdominal pain, rebound tenderness Cloudy effluent with increased WBCs or bacteria, may have fever GI: diarrhea, vomiting, distention, hyperactive bowel sounds Treated with antibiotics Repeated infections may cause adhesions Hernias: Increased intra-abdominal pressure from dialysate Treatment: hernia repair Bleeding Common with initial catheter placement New; Active intraperitoneal bleeding; check BP & hematocrit Pulmonary complications Decreased lung expansion leads to atelectasis, pneumonia, or bronchitis Elevate HOB, repositioning & deep breathing Protein loss; Monitor nutrition Lower back problems Intraperitoneal infusion increases pressure Treatment: binders and exercise
62
Peritoneal Dialysis – Effectiveness of Chronic PD
Short training program; 3 to 7 days Advantages Simplicity Home-based program Increasing patient participation No need for special water systems Equipment set-up is relatively simple
63
Hemodialysis (HD) Vascular Access
Requires rapid blood flow & access to large blood vessel Obtaining vascular access is one of most difficult problems AV Fistula: Created in forearm or upper arm; Preferred access for HD Allows arterial blood to flow through vein; becomes “arterialized; Increases vein size & wall thickness Placed 3-months before HD; Needs to heal/mature “Thrill” & “Bruit” (High velocity blood flow) AV Graft: Synthetic material surgically placed under skin to form a “bridge” between brachial artery & antecubital vein Temporary vascular access
64
AV Fistulas & Grafts
Healing: 2 to 4 weeks More likely to get infected or form clots If infected, may need removed Risks: Distal ischemia (Steal Syndrome) Pain distal to access site Numbness or tingling of fingers Poor capillary refill Aneurysms Safety alert for AVF & grafts No BP, venipunctures, or IV lines Post signs in room & labeled arm band Prevent infection & clotting HeRO Graft (Hemodialysis Reliable Outflow) Special bridge access used when other access options are exhausted Two pieces Reinforced tube to bypass blockages Dialysis graft anastomosed to an artery; placed under skin Bypasses venous system; blood flows from target artery to heart
65
Hemodialysis Dialyzer
Plastic cartridges that contain thousands of parallel hollow tubes or fibers; semipermeable membranes Blood is pumped from top into fibers Dialysate pumped from bottom & bathes outside of fibers Ultrafiltration, diffusion & osmosis occur When blood reaches end it is returned via single tube to patient
66
Hemodialysis Procedure
Fluid status assessed before HD treatment Weight, BP, peripheral edema, heart & lung sounds Last post-dialysis weight & current pre-dialysis weight determines amount of fluid to be removed Assess vascular access & temperature Two large bore needles placed in fistula or graft One to pull blood from circulation to HD machine Other to return dialyzed blood to patient Dialyzer/blood lines primed with NaCL to eliminate air; Heparin added to prevent clotting Dialysate delivery & monitoring system is used; VS every 30 - 60 minutes, Terminated with saline flush to return all blood to patient, Needles removed & firm pressure applied Most in community-based center; Dialyzed 3 - 4 hours, 3 days/week Other options; Short daily HD, Long nocturnal HD, Home HD
67
Hemodialysis Complications
Hypotension; Hypovolemia, decreased CO & SVR; Light-headed, nausea, seizures, vision changes, & chest pain Treatment: Decrease volume of fluid removal & IV Normal Saline Muscle cramps; Decreased BP, hypovolemia, increased ultrafiltration, & low-sodium dialysate Treatment: Decrease ultrafiltration & give IV fluids Blood loss; Blood not rinsed from dialyzer, accidental separation of tubing, dialysis membrane rupture or bleeding after needles removed; Heparin Treatment: Rinse all blood back, avoid excess Heparin, hold pressure to access sites Hepatitis C (8% to 10% develop): Infection control precautions Hepatitis B: low incidence; administer vaccine
68
Hemodialysis Effectiveness
Cannot fully replace normal function of kidneys Can ease many of symptoms Can prevent certain complications CV disease carries high mortality rate Infectious complications 2nd leading cause of death Individual adaptation Positive Ambivalent Depressed Nursing goals: Help patient to: have a healthy self-image return to highest level of function
69
Wearable Artificial Kidney (WAK) 1st Clinical Trial 2015 – 7 Patients
Battery operated Requires only 370 mL water Versus 40-gallons for HD Early model 11-pounds Latest model 2-pounds Device connected via one catheter surgically inserted in 20-minute procedure under a local anesthetic